Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 3
1964 10
1965 1
1966 1
1967 3
1968 4
1969 9
1970 9
1971 4
1972 9
1973 4
1974 17
1975 13
1976 6
1977 8
1978 6
1979 4
1980 7
1981 11
1982 10
1983 6
1984 5
1985 5
1986 7
1987 15
1988 15
1989 23
1990 37
1991 27
1992 28
1993 26
1994 39
1995 44
1996 31
1997 49
1998 37
1999 39
2000 48
2001 58
2002 51
2003 40
2004 53
2005 39
2006 75
2007 67
2008 74
2009 62
2010 67
2011 63
2012 78
2013 76
2014 116
2015 107
2016 100
2017 106
2018 106
2019 99
2020 93
2021 114
2022 100
2023 115
2024 44

Text availability

Article attribute

Article type

Publication date

Search Results

2,309 results

Results by year

Filters applied: . Clear all
Page 1
Liver cirrhosis.
Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, Kamath PS. Ginès P, et al. Lancet. 2021 Oct 9;398(10308):1359-1376. doi: 10.1016/S0140-6736(21)01374-X. Epub 2021 Sep 17. Lancet. 2021. PMID: 34543610 Review.
Progressive portal hypertension, systemic inflammation, and liver failure drive disease outcomes. ...In this Seminar, we discuss the disease burden, pathophysiology, and recommendations for the diagnosis and management of cirrhosis and its complications. Future challenges …
Progressive portal hypertension, systemic inflammation, and liver failure drive disease outcomes. ...In this Seminar, we discuss the …
Liver fibrosis.
Bataller R, Brenner DA. Bataller R, et al. J Clin Invest. 2005 Feb;115(2):209-18. doi: 10.1172/JCI24282. J Clin Invest. 2005. PMID: 15690074 Free PMC article. Review.
Advanced liver fibrosis results in cirrhosis, liver failure, and portal hypertension and often requires liver transplantation. Our knowledge of the cellular and molecular mechanisms of liver fibrosis has greatly advanced. Activated hepatic stellate cells, …
Advanced liver fibrosis results in cirrhosis, liver failure, and portal hypertension and often requires liver transplantation. …
Porto-sinusoidal vascular disorder.
De Gottardi A, Sempoux C, Berzigotti A. De Gottardi A, et al. J Hepatol. 2022 Oct;77(4):1124-1135. doi: 10.1016/j.jhep.2022.05.033. Epub 2022 Jun 9. J Hepatol. 2022. PMID: 35690264 Free article. Review.
However, similar histological abnormalities primarily affecting the hepatic sinusoidal and (peri)portal vasculature have also been observed in patients without portal hypertension. ...Specific histology findings include nodular regenerative hyperplasia, obliterative …
However, similar histological abnormalities primarily affecting the hepatic sinusoidal and (peri)portal vasculature have also been ob …
Liver cirrhosis.
Tsochatzis EA, Bosch J, Burroughs AK. Tsochatzis EA, et al. Lancet. 2014 May 17;383(9930):1749-61. doi: 10.1016/S0140-6736(14)60121-5. Epub 2014 Jan 28. Lancet. 2014. PMID: 24480518 Review.
Mechanisms of liver fibrosis and its role in liver cancer.
Dhar D, Baglieri J, Kisseleva T, Brenner DA. Dhar D, et al. Exp Biol Med (Maywood). 2020 Jan;245(2):96-108. doi: 10.1177/1535370219898141. Epub 2020 Jan 10. Exp Biol Med (Maywood). 2020. PMID: 31924111 Free PMC article. Review.
In this review, we focus on key cell-types that contribute to liver fibrosis, cytokines, and chemokines influencing this process and what it takes for fibrosis to regress. We discuss how mitochondria and metabolic changes in hepatic stellate cells modulate the fibro …
In this review, we focus on key cell-types that contribute to liver fibrosis, cytokines, and chemokines influencing this process and …
Non-cirrhotic portal hypertension - diagnosis and management.
Khanna R, Sarin SK. Khanna R, et al. J Hepatol. 2014 Feb;60(2):421-41. doi: 10.1016/j.jhep.2013.08.013. Epub 2013 Aug 23. J Hepatol. 2014. PMID: 23978714 Free article. Review.
In EHPVO, there are additional concerns of growth faltering, portal biliopathy, MHE and parenchymal dysfunction. Surgical shunts are indicated in patients with failure of endotherapy, bleeding from sites not amenable to endotherapy, symptomatic hypersplenism or symptomatic …
In EHPVO, there are additional concerns of growth faltering, portal biliopathy, MHE and parenchymal dysfunction. Surgical shunts are …
Hepatic fibrosis 2022: Unmet needs and a blueprint for the future.
Friedman SL, Pinzani M. Friedman SL, et al. Hepatology. 2022 Feb;75(2):473-488. doi: 10.1002/hep.32285. Epub 2022 Jan 11. Hepatology. 2022. PMID: 34923653 Review.
These include the need to better define cell-cell interactions and etiology-specific elements of fibrogenesis and their link to disease-specific drivers of portal hypertension. Success in treating viral hepatitis has revealed the remarkable capacity of the liver to degrade …
These include the need to better define cell-cell interactions and etiology-specific elements of fibrogenesis and their link to disease-spec …
Fibrosis and alcohol-related liver disease.
Lackner C, Tiniakos D. Lackner C, et al. J Hepatol. 2019 Feb;70(2):294-304. doi: 10.1016/j.jhep.2018.12.003. J Hepatol. 2019. PMID: 30658730 Review.
In contrast to most chronic liver diseases where fibrosis is portal-based, fatty liver disease (FLD) of alcoholic or non-alcoholic aetiology (NAFLD) is associated with a centrilobular pattern of injury which leads to perivenular fibrosis and/or pericellular …
In contrast to most chronic liver diseases where fibrosis is portal-based, fatty liver disease (FLD) of alcoholic or non-alcoh …
Ascites in Children.
Bavdekar A, Thakur N. Bavdekar A, et al. Indian J Pediatr. 2016 Nov;83(11):1334-1340. doi: 10.1007/s12098-016-2168-1. Epub 2016 Jun 9. Indian J Pediatr. 2016. PMID: 27278239 Review.
In children, hepatic, renal and cardiac disorders are the most common causes. Portal hypertension and sodium and fluid retention are key factors in the pathophysiology of ascites. ...The serum-ascites albumin gradient (SAAG) is the best single test for classifying ascites …
In children, hepatic, renal and cardiac disorders are the most common causes. Portal hypertension and sodium and fluid retention are …
Cirrhosis and Portal Hypertension: How Do We Deal with Ascites and Its Consequences.
Tonon M, Piano S. Tonon M, et al. Med Clin North Am. 2023 May;107(3):505-516. doi: 10.1016/j.mcna.2022.12.004. Epub 2023 Feb 20. Med Clin North Am. 2023. PMID: 37001950 Review.
Complications of ascites (ie, spontaneous bacterial peritonitis, hepatorenal syndrome, recurrent/refractory ascites, and hepatic hydrothorax) further worsen survival. The development of ascites is driven by portal hypertension, systemic inflammation, and splanchnic arteria …
Complications of ascites (ie, spontaneous bacterial peritonitis, hepatorenal syndrome, recurrent/refractory ascites, and hepatic hydrothorax …
2,309 results